Clinical Trial Result Information

Protocol number
WA17823

Title of Study
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients with Moderate to Severe Active Rheumatoid Arthritis

Sponsor
Roche Products Ltd.

Company division
Pharmaceutical

Product name
tocilizumab

Therapeutic area
Rheumatoid arthritis

Clinical study summary
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.

Phase of development
III

Date of report
To be Published

Click here for the protocol registry listing of this trial.